1Kleinpell R.Advances in treating patients with severe sepsis[J].Crit Care Nurse,2003,23:16 -29.
2Echtenacher B,Weigl K,Lehn N,et al.Tumor necrosis factor-dependent adhesions as a major protective mechanism early in septic peritonitis in mice[J].Infect Immun,2001,69:3550-3555.
4Vasselon T,Detmers PA.Toll receptors:a central element in innate immune responses[J].Infect Immun,2002,14:103-110.
5Oberholzer A,Oberholzer C,Moldawer LL.Sepsis syndromes:understanding the role of innate and acquired immunity[J].Shock,2001,16:83-96.
6Gogos CA,Drosou E,Bassaris HP,et al.Pro-versus anti -inflammatory cytokine profile in patients with severe sepsis:a marker for prognosis and future therapeutic options[J].J Infect Dis,2000,181:176-180.
7Pellegrini JD,De AK,Kodys K,et al.Relationships between T lymphocyte apoptosis and anergy following trauma[J].J Surg Res,2000,88:200-206.
8Hotchkiss RS,Tinsley KW,Swanson PE,et al.Depletion of dendritic cells,but not macrophages,in patients with sepsis[J].J Immunol,2002,168:2493-2500.
9Hotchkiss RS,Chang KC,Swanson PE,et al.Caspase inhibitors improve survival in sepsis:a critical role of the lymphocyte[J].Nat Immunol,2001,1:496-501.
10Freeman BD,Buchman TG.Gene in a haystack:tumor necrosis factor polymorphisms and outcome in sepsis[J].Crit Care Med,2000,28:3090-3091.
7Dombrovskiy VY,Martin AA,Sunderram J,et al. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States:a trend analysis from 1993 to 2003[J]. Crit Care Med, 2007, 35(5 ) : 1244-1250.
8Miyara M,Sakaguchi S.Natural regulatory T cells:mechanisms of suppression[J]. Trends Mol Med, 2007,13 (3) : 108-116.
9Levy MM, Fink MP, Marshall JC,et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference[J]. Crit Care Med, 2003,31 (4): 1250-1256.
10Guo RF,Peter A.Ward mediators and regulation of neutrophil accu-mulation in inflammatory responses in lung:insights from the IgG im-mune complex model[J].Free Radic Biol Med,2002,33(3):303.
